8 Coupons
-
Special Offer
-
30% off
'indian ip and liabilities law barrier to pharma r&d investment'
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.copyright © 2018 bennett, coleman & co. ltd. all rights reserved.
.of all car-t cell trials registered since 2001, more than half are being conducted in china.
.
but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment. .